O(6)-methylguanine-DNA methyltransferase promoter methylation and isocitrate dehydrogenase mutation as prognostic factors in a cohort of Saudi patients with glioblastoma

BACKGROUND: Treatment of glioblastoma (GB), the most common malignant primary brain tumor in adults, can include alkylating chemo-therapeutic agents. Two molecular biomarkers of treatment response are MGMT (O(6)-methylguanine-DNA methyltransferase) promoter methylation and IDH (isocitrate dehydrogen...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Saudi Med
Prif Awduron: Alassiri, Ali H., Alkhaibary, Ali, Al-Sarheed, Saud, Alsufani, Fahd, Alharbi, Mohammed, Alkhani, Ahmed, Aloraidi, Ahmed
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: King Faisal Specialist Hospital and Research Centre 2019
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6894451/
https://ncbi.nlm.nih.gov/pubmed/31804140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5144/0256-4947.2019.410
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg